meperidine hydrochloride
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
10 FDA-registered drug labelers
Curia New York, Inc.
EPIC PHARMA, LLC
Genus Lifesciences Inc.
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Medisca Inc.
Pharma Source Direct, Inc.
Professional Compounding Centers of America dba PCCA
SpecGx LLC
Spectrum Laboratory Products, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Demerol
- •Meperidine Hydrochloride
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Meperidine Hydrochloride Injection
05/30/2025Unavailable
current
Meperidine Hydrochloride Injection
05/30/2025Limited Availability
current
Meperidine Hydrochloride Injection
05/30/2025Available
Chemical Identity
CAS50-13-5
PubChem CID5750
DTXSIDDTXSID30950620
FormulaC15H22ClNO2
Mol. Weight283.79 g/mol
SMILESCCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.Cl
Data Sources
57502026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/meperidine hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/meperidine hydrochloride.json
CAS 50-13-52026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 50-13-52026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json